Аннотация:
The objective. To evaluate the incidence and prevalence of hepatitis C in Russia and estimate the impact of hepatitis C virus on liver cirrhosis, hepatocellular carcinoma and liver-related mortality before the implementation of the national program for the elimination of viral hepatitis. Materials and methods. We analyzed statistical data on the incidence of hepatitis C in Russia in 2001–2017, the incidence, prevalence and mortality rates from liver cirrhosis and malignant liver tumors in 2011–2015. An analysis of the incidence and prevalence of HCV was carried out in various age-sex groups. The structure of genotypes of the hepatitis C virus was determined in patients at different stages of liver fibrosis and with different levels of viral load. Results. In 2017, 50 798 cases of HCV were registered in Russia (34.6 per 100 thousand of the population). As of January 1, 2017, the total number of patients with chronic hepatitis C under medical observation was 591 830 (405 per 100 thousand
Пименов Н. Н.
Комарова С. В.
Карандашова И. В.
Цапкова Н. Н. Наталья Николаевна 1953-
Волчкова Е. В. Елена Васильевна 1953-
Чуланов В. П. Владимир Петрович 1970-
Pimenov N. N.
Komarova S. V.
Karandashova I. V.
Tsapkova N. N. Natal`ya Nikolaevna 1953-
Volchkova E. V. Elena Vasilyevna 1953-
Chulanov V. P. Vladimir Petrovich 1970-
Hepatitis C and its outcomes in Russia: Analysis of incidence, prevalence and mortality rates before the start of the programme of infection elimination
Hepatitis C and its outcomes in Russia: Analysis of incidence, prevalence and mortality rates before the start of the programme of infection...
Текст визуальный непосредственный
Инфекционные болезни
ООО "Издательство "Династия"
Т. 16, Вып. 3 С. 37-45
2018
Статья
Cirrhosis Diagnostics Epidemiology Genotype Hepatocellular carcinoma Prevention Surveillance Treatment
The objective. To evaluate the incidence and prevalence of hepatitis C in Russia and estimate the impact of hepatitis C virus on liver cirrhosis, hepatocellular carcinoma and liver-related mortality before the implementation of the national program for the elimination of viral hepatitis. Materials and methods. We analyzed statistical data on the incidence of hepatitis C in Russia in 2001–2017, the incidence, prevalence and mortality rates from liver cirrhosis and malignant liver tumors in 2011–2015. An analysis of the incidence and prevalence of HCV was carried out in various age-sex groups. The structure of genotypes of the hepatitis C virus was determined in patients at different stages of liver fibrosis and with different levels of viral load. Results. In 2017, 50 798 cases of HCV were registered in Russia (34.6 per 100 thousand of the population). As of January 1, 2017, the total number of patients with chronic hepatitis C under medical observation was 591 830 (405 per 100 thousand